PubMed:23580652 / 243-478 JSONTXT

{"project":"sentences","denotations":[{"id":"T3","span":{"begin":0,"end":235},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"In Alzheimer disease (AD) and individuals with mild cognitive impairment converting to AD, plasma sLRP1 levels are reduced and sLRP1 is oxidized, which results in diminished Aβ peripheral binding and higher levels of free Aβ in plasma."}

{"project":"Allie","denotations":[{"id":"SS1_23580652_2_0","span":{"begin":3,"end":20},"obj":"expanded"},{"id":"SS2_23580652_2_0","span":{"begin":22,"end":24},"obj":"abbr"}],"relations":[{"id":"AE1_23580652_2_0","pred":"abbreviatedTo","subj":"SS1_23580652_2_0","obj":"SS2_23580652_2_0"}],"text":"In Alzheimer disease (AD) and individuals with mild cognitive impairment converting to AD, plasma sLRP1 levels are reduced and sLRP1 is oxidized, which results in diminished Aβ peripheral binding and higher levels of free Aβ in plasma."}

{"project":"PubmedHPO","denotations":[{"id":"T2","span":{"begin":3,"end":20},"obj":"HP_0002511"},{"id":"T3","span":{"begin":52,"end":72},"obj":"HP_0100543"}],"text":"In Alzheimer disease (AD) and individuals with mild cognitive impairment converting to AD, plasma sLRP1 levels are reduced and sLRP1 is oxidized, which results in diminished Aβ peripheral binding and higher levels of free Aβ in plasma."}

{"project":"GlyCosmos15-HP","denotations":[{"id":"T1","span":{"begin":3,"end":20},"obj":"Phenotype"},{"id":"T2","span":{"begin":22,"end":24},"obj":"Phenotype"},{"id":"T3","span":{"begin":52,"end":72},"obj":"Phenotype"},{"id":"T4","span":{"begin":87,"end":89},"obj":"Phenotype"}],"attributes":[{"id":"A1","pred":"hp_id","subj":"T1","obj":"HP:0002511"},{"id":"A2","pred":"hp_id","subj":"T2","obj":"HP:0002511"},{"id":"A3","pred":"hp_id","subj":"T3","obj":"HP:0100543"},{"id":"A4","pred":"hp_id","subj":"T4","obj":"HP:0002511"}],"namespaces":[{"prefix":"HP","uri":"http://purl.obolibrary.org/obo/HP_"}],"text":"In Alzheimer disease (AD) and individuals with mild cognitive impairment converting to AD, plasma sLRP1 levels are reduced and sLRP1 is oxidized, which results in diminished Aβ peripheral binding and higher levels of free Aβ in plasma."}

{"project":"mondo_disease","denotations":[{"id":"T3","span":{"begin":3,"end":20},"obj":"Disease"},{"id":"T4","span":{"begin":22,"end":24},"obj":"Disease"},{"id":"T5","span":{"begin":87,"end":89},"obj":"Disease"}],"attributes":[{"id":"A3","pred":"mondo_id","subj":"T3","obj":"http://purl.obolibrary.org/obo/MONDO_0004975"},{"id":"A4","pred":"mondo_id","subj":"T4","obj":"http://purl.obolibrary.org/obo/MONDO_0004975"},{"id":"A5","pred":"mondo_id","subj":"T5","obj":"http://purl.obolibrary.org/obo/MONDO_0004975"}],"text":"In Alzheimer disease (AD) and individuals with mild cognitive impairment converting to AD, plasma sLRP1 levels are reduced and sLRP1 is oxidized, which results in diminished Aβ peripheral binding and higher levels of free Aβ in plasma."}

{"project":"Anatomy-UBERON","denotations":[{"id":"T4","span":{"begin":91,"end":97},"obj":"Body_part"},{"id":"T5","span":{"begin":228,"end":234},"obj":"Body_part"}],"attributes":[{"id":"A4","pred":"uberon_id","subj":"T4","obj":"http://purl.obolibrary.org/obo/UBERON_0001969"},{"id":"A5","pred":"uberon_id","subj":"T5","obj":"http://purl.obolibrary.org/obo/UBERON_0001969"}],"text":"In Alzheimer disease (AD) and individuals with mild cognitive impairment converting to AD, plasma sLRP1 levels are reduced and sLRP1 is oxidized, which results in diminished Aβ peripheral binding and higher levels of free Aβ in plasma."}